Alpha-9 Oncology received $175 Million in Series C financing round

Alpha-9 Oncology received $175 Million in Series C financing round

Alpha-9 Oncology Inc has announced that it has received $175 Million from Lightspeed Venture Partners and Ascenta Capital in Series C round including from existing investors and other top-tier new investor.

Please login to comment on this Post

Most Visited Posts

1

Greek Catering in Valley Metro – Office, Event & Party Catering That Actually Works

If you’re searching for Greek catering in...

2

The Key Role of Construction Hoarding in Perth

Construction hoarding in Perth is more than...

3

DNA Sequencing Market Trend to be Worth $21.30 Billion by 2031

Genomics research supported by NGS has identified genetic heterogeneity even among cancer types that were earlier considered identical. The discovery of unique molecular signatures is helping in the development of potential cancer treatments, increasing the demand for NGS in cancer research.

4

هل عملية استبدال الركبة مناسبة لك؟ استكشاف الخيارات المتاحة في نيجيريا

غالبًا ما يتم النظر في...

5

Elevate Your Home With 9 Different Types of Stairs

Types of Stairs Stairs are an essential element...

6

What Is Pineapple Good For in Males?

Pineapple isn't just a tropical...

7

IVD Reagents Market Landscape: Segmentation, Opportunities, and Strategic Insights

The global in-vitro diagnostic (IVD) reagents...

8

List of Best Hospitals in Brisbane, Queensland

List of Best Hospitals in Brisbane,...

9

Motorized Roller Conveyor System

Perfection Engineering presents its cutting-edge...

10

Why Wholesale Scarves and Accessories UK Should Be Your Go-To for Retail

In today’s competitive retail landscape,...

Follow Us on